Isotretinoin, often called by the brand name Accutane, can cause hair loss, but it is not one of its common side effects. The drug label lists it, and a 2022 review of 22 studies found it in roughly 3 to 6 percent of people treated for acne. It usually shows up as shedding spread across the scalp. Whether it always settles after the course is a question the research has not answered well.
That gap is where a record helps. If you write down the date you started, take matched photos and note how much hair you see on wash days, you and your dermatologist can see whether the timing fits the drug or points somewhere else.
TL;DR
- The ABSORICA label and MedlinePlus both list hair loss as a possible side effect of isotretinoin.
- A 2022 systematic review found hair loss in 3.2 percent of patients on lower daily doses and 5.7 percent on higher ones; the authors could not test whether that gap was real.
- The usual pattern is telogen effluvium: more hairs shed from all over the scalp, not round bald patches.
- The label says the loss persisted in some cases; the review found no definitive evidence on how often that happens.
- Do not stop or change a course on your own. Record dates, photos and shedding, and take them to your prescriber.
Important
This article is educational and not medical advice. If you are worried about sudden shedding, scalp symptoms, or side effects, talk to a licensed clinician.
What the label and drug guides say
The prescribing information for ABSORICA, one isotretinoin brand, lists alopecia among skin reactions found in clinical trials or postmarketing reports. It also lists “alopecia (which in some cases persisted).” The label explains that some of these reports came in voluntarily from an unknown number of users, so their frequency cannot be estimated reliably (ABSORICA label on DailyMed).
The MedlinePlus drug guide for isotretinoin, from the US National Library of Medicine, lists “hair loss or unwanted hair growth” among the side effects to tell a doctor about (MedlinePlus: isotretinoin). Neither source says how likely it is for one person.
How often it happens, and the dose finding
The best summary so far is a systematic review that pooled 22 studies of acne patients who reported hair loss on isotretinoin. Among people on less than 0.5 mg per kilogram of body weight a day, 18 of 565 (3.2 percent) reported hair loss. Among people on 0.5 mg/kg a day or more, 192 of 3,375 (5.7 percent) did (Lytvyn and colleagues, 2022).
Read that as a finding, not as a guide to choosing a dose. The authors say a statistical comparison between the two groups was not possible: the studies differed too much, and the higher-dose group was six times larger. Most studies were not randomised, most hair outcomes were reported by patients rather than measured, and there was no data on iron deficiency or on differences between men and women. The authors call the dose pattern a possible trend that needs better research. Your dose and course length are decisions for your prescriber.
A records review at UCLA points the same way with a different method. Of 6,330 patients seen for hair loss between 2013 and 2018, 48 had been prescribed isotretinoin, and in 19 the hair loss began during the course or within two years after it. Compared with isotretinoin users who had no hair loss, those 19 were older, had a higher total dose and had been treated for longer (Tran and colleagues, 2022). The authors note the small number of cases, the look-back design, and that they did not check other causes such as hormonal contraception or family history.
Not every study found a change. A Turkish study measured hair count, density and the share of resting hairs with TrichoScan, a camera-based scalp analysis, before and after three months of isotretinoin. The differences it saw were not statistically significant (a 2019 study by İslamoğlu and Altınyazar). Three months is short, and a group average can hide a few people who shed a lot.
What kind of hair loss it is
The review describes isotretinoin hair loss as telogen effluvium: more follicles than usual move into the resting phase at once and then shed together, so the loss is spread across the scalp. The exact mechanism is not known. The same review notes that drug-related shedding of this kind has been reported to begin after about 12 weeks of treatment, while one small group whose dose was raised noticed it at a median of 4 weeks (Lytvyn and colleagues, 2022).
The American Academy of Dermatology says most people with this kind of shedding notice it a few months after the trigger, and lists other common triggers: losing a lot of weight, high fever, an operation, serious stress and stopping birth-control pills (AAD: hair loss or hair shedding). A course of isotretinoin often overlaps with some of these, which is one reason a dated log is worth keeping. For how shedding differs from pattern hair loss, see telogen effluvium vs male pattern baldness.
What is not known
- Whether a higher daily dose really causes more hair loss. The review saw a gap but could not test it.
- Whether total dose matters. The UCLA review found an association; the systematic review said the data could not settle it.
- How often the loss lasts after treatment. The label reports persistent cases; the review found no definitive evidence either way.
- Whether isotretinoin brings forward pattern hair loss in people already prone to it. None of the sources above tested this.
- Who is most at risk. Older age came up in one small study, and the systematic review had too little data to compare men and women.
What to track during a course
The aim is a record you can hand to a doctor, not a home diagnosis. If you can, start before the first capsule, so you have a baseline.
- Dates: the day you started, any change your prescriber made, and the day the course ended.
- Photos: hairline, both temples, the crown and your usual part, in the same light, from the same distance and angle, with hair dry and styled the same way. See how often to take progress photos.
- Shedding notes: on wash days, note roughly how much hair you see in the drain or on the towel, in the same words or count each time.
- Other events: illness with fever, big weight change, surgery, a stressful period, or starting or stopping hormonal contraception.
- Anything that looks different: round bald patches, redness, scaling or scalp pain. Those are not typical of drug shedding.
When you compare photos, put dates that are months apart side by side and mark any pair where the light or angle changed as hard to compare. One bad photo is not a trend. For a method that keeps the comparison fair, see comparing hair photos without bias.
When to talk to a doctor
The American Academy of Dermatology advises talking with your doctor if you think a drug is causing hair loss, and warns that stopping a treatment suddenly can cause serious side effects (AAD: hair loss or hair shedding). So raise it with your prescriber rather than changing the course yourself. Book a visit sooner if you see patches, redness or pain, if the shedding keeps going for months after the course ended, or if it worries you. A dermatologist diagnoses hair loss from your history and a scalp exam, sometimes with further tests (AAD diagnosis overview), so bring the record you have, even if it is short. See also when to see a dermatologist for hair loss.
Next step
Before or early in a course, take one set of baseline photos in fixed light and write down your start date. Add short shedding notes on wash days. If the shedding rises, that record lets your prescriber judge the timing instead of guessing.
Related reading
- Telogen effluvium vs male pattern baldness
- How to track hair loss
- When to see a dermatologist for hair loss
- Does Adderall cause hair loss?
Sources: Lytvyn et al. 2022, JAAD International; Tran et al. 2022, International Journal of Trichology; İslamoğlu and Altınyazar 2019, Journal of Cosmetic Dermatology; ABSORICA (isotretinoin) prescribing information, DailyMed; MedlinePlus: isotretinoin; AAD: hair loss or hair shedding; AAD: hair loss diagnosis and treatment.
